Lucid Diagnostics (LUCD) Net Income Growth (1y) (2021 - 2026)
Lucid Diagnostics (LUCD) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | 125.69% |
| 10 | Lucid Diagnostics | 127.21 Mn | 99.33 Mn | -325,000.00 | 48.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.31% |
| Dec 31, 2025 | -40.94% |
| Sep 30, 2025 | 15.96% |
| Jun 30, 2025 | 59.66% |
| Mar 31, 2025 | -153.56% |
| Dec 31, 2024 | -6.57% |
| Sep 30, 2024 | 12.93% |
| Jun 30, 2024 | 3.30% |
| Mar 31, 2024 | 34.68% |
| Dec 31, 2023 | 27.45% |
| Sep 30, 2023 | 0.98% |
| Jun 30, 2023 | 22.18% |
| Mar 31, 2023 | -32.41% |
| Dec 31, 2022 | -32.04% |
| Sep 30, 2022 | -106.25% |
| Jun 30, 2022 | -137.29% |
| Mar 31, 2022 | -235.89% |
| Dec 31, 2021 | -313.97% |
| Sep 30, 2021 | -244.12% |